Prothix is a new biopharmaceutical company focused on the development of protein therapeutics in the field of coagulation and inflammation. All products developed by Prothix are monoclonal antibody products. These products can be developed along a similar trajectory , which includes humanization and deimmunization, generation of manufacturing cell-lines, and development of a manufacturing process.